Methodological gaps in the assessment of risk minimization interventions: a systematic review. - Wikidata - wikimedia - TriplyDB

Methodological gaps in the assessment of risk minimization interventions: a systematic review.

Methodological gaps in the assessment of risk minimization interventions: a systematic review.

http://www.wikidata.org/entity/Q38195003

about

Advancing the field of pharmaceutical risk minimization through application of implementation science best practices.Evaluating the effectiveness of risk minimisation measures: the application of a conceptual framework to Danish real-world dabigatran data.Integrating risk minimization planning throughout the clinical development and commercialization lifecycle: an opinion on how drug development could be improved.A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU.Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey.Study Design and Evaluation of Risk Minimization Measures: A Review of Studies Submitted to the European Medicines Agency for Cardiovascular, Endocrinology, and Metabolic Drugs.Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations.The RIMES Statement: A Checklist to Assess the Quality of Studies Evaluating Risk Minimization Programs for Medicinal Products.A review of studies evaluating the effectiveness of risk minimisation measures in Europe using the European Union electronic Register of Post-Authorization Studies.

P2860

Q34051864-7EFBB66D-9934-440B-AC29-EB521B3AD470 Q36342841-262E70D8-A5BF-4937-B4EA-E3F72D726F1A Q38391532-9D4CA9FE-8FAA-4E00-B415-BEC864B0AEF9 Q38874756-F84BD79B-701E-426E-99F3-AEC26EA056E3 Q47161547-D19AED11-EEDC-4199-BC39-BC6450911F4C Q47619604-DB6EA010-6945-46E0-A692-21CDBF2A9812 Q47653552-0956EA5A-FBAF-4735-8AF8-8005811E8DCF Q50016764-8D63A66D-36EF-4D30-BEDC-1993224E0950 Q52804934-8BFD135B-07A2-4965-884A-1F3CBFBDC098

P2860

Methodological gaps in the assessment of risk minimization interventions: a systematic review.

http://www.wikidata.org/entity/Q38195003

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Methodological gaps in the ass ...... ventions: a systematic review.

@en

type

label

Methodological gaps in the ass ...... ventions: a systematic review.

@en

prefLabel

Methodological gaps in the ass ...... ventions: a systematic review.

@en

P1433

Q38195003-FC630709-8EA7-47F2-8793-795B008C2707

P1476

Q38195003-21475F1B-58E9-403E-882A-C91D5C9FB073

P2093

Q38195003-040D857A-D88C-462B-B8AA-49EDDEC8391B

Q38195003-4F25FC08-FFD1-4B16-ACD7-782C46C983B1

Q38195003-68891BC1-9A1C-4C93-A018-575AF708F1B0

Q38195003-ACB5997B-048A-40BE-A978-9F51498253E2

Q38195003-DAB80CC7-84C1-4DDB-BBF7-DF945D5815E9

Q38195003-E0734F20-51AF-480A-9607-9101A297CF68

P2860

Q38195003-02F70FD1-4FFA-4B67-9F32-9D114B537C24

Q38195003-0BAF2926-9598-402A-926D-3E35CCACD618

Q38195003-0F45497E-6460-47C1-9A98-7BC4BEE4FB04

Q38195003-18D020CF-C205-4016-A8BA-C3953E4751F0

Q38195003-1D8EB21B-5FE9-4303-90CA-843D3EA6CD08

Q38195003-1F5147E0-C00D-4A78-8855-3E5219F71C04

Q38195003-20130244-D2BC-4C86-8EBE-EDEC03BB164B

Q38195003-2843C773-8414-4154-9C70-22511B947683

Q38195003-2CDEB594-97EC-40EF-9CB8-59719EF348B1

Q38195003-354D1BB2-9BDB-4F66-89E8-B8C1BC7CB1B9

P304

Q38195003-F7CBBF98-1183-442B-BFF5-A52807E0F981

P31

Q38195003-32D950ED-3D2A-480A-9EFA-09CCB2A9D7D7

P356

Q38195003-5E505C5C-FCF3-45D3-99DF-92AF0FE66003

P433

Q38195003-DD74FF3A-CC91-4491-99FD-D8AF54BE1A0E

P478

Q38195003-D48CB138-A634-4C1F-82AE-0053D158C782

P577

Q38195003-44B0149F-A3E4-4D52-BBC5-0741B7A46993

P5875

Q38195003-465E76FB-92E6-4243-A617-6BF717D691BE

P698

Q38195003-5F2C052C-ECA6-49F8-9586-9AB7FF0197E9

P356

P1433

Pharmacoepidemiology and Drug Safety

P1476

Methodological gaps in the ass ...... ventions: a systematic review.

@en

P2093

Anne-Marie Cloutier

http://www.w3.org/2001/XMLSchema#string

Camille Craig

http://www.w3.org/2001/XMLSchema#string

Inna Gridchyna

http://www.w3.org/2001/XMLSchema#string

Lenhangmbong Nkeng

http://www.w3.org/2001/XMLSchema#string

Sarah Frise

http://www.w3.org/2001/XMLSchema#string

Yola Moride

http://www.w3.org/2001/XMLSchema#string

P2860

Why don't physicians follow clinical practice guidelines? A framework for improvement

Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.

Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.

Impact of FDA black box advisory on antipsychotic medication use

Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters.

Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents.

Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity.

The impact of wording in "Dear doctor" letters and in black box labels.

Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes

Impact of mailed warning to prescribers on the co-prescription of tramadol and antidepressants.

P304

572-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PDS.3596

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260684345

http://www.w3.org/2001/XMLSchema#string

P698

24616240

http://www.w3.org/2001/XMLSchema#string